Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;81(5):628-636.
doi: 10.1002/ddr.21667. Epub 2020 Mar 31.

Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases

Yeliz Demir  1
Affiliations

Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases

Yeliz Demir. Drug Dev Res. 2020 Aug.

Abstract

Paraoxonase-1 (PON1) has essential roles such as protecting low-density lipoprotein against detoxification and oxidation of highly toxic compounds. Quinones are a class of compounds and a type of plant-derived secondary metabolites. Here, PON1 was purified using very simple methods and evaluation of the interactions between the enzyme and some quinones. It was found that these quinones displayed effective inhibitor properties for PON1 with the IC50 values in the range of 3.27-82.90 μM and the K i values in the range of 2.50 ± 0.65 to 30.90 ± 7.20 μM. These quinones displayed distinct inhibition mechanisms. It was determined that except for 5-hydroxy-2-methyl-1,4-naphthoquinone and 2-methyl-1,4-naphthoquinone all quinones exhibit competitive inhibition effects. Also, molecular docking and in silico ADME studies were performed. Usage of drugs including quinone derivatives in structure with biological activity would be hazardous in some cases.

Keywords: enzyme inhibition; molecular docking; oxidative stress; paraoxonase; quinones.

PubMed Disclaimer

References

REFERENCES

    1. Ahmad, N., Ahmad, R., Ahmad, F. J., Ahmad, W., Alam, M. A., Amir, M., & Ali, A. (2020). Poloxamer-chitosan-based naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia. Saudi Journal of Biological Sciences, 27(1), 500-517.
    1. Ahmad, N., Ahmad, R., Alam, M. A., & Ahmad, F. J. (2018). Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral ischemia. Drug Research (Stuttgart), 68(10), 584-595.
    1. Ahmad, N., Ahmad, R., Naqvi, A. A., Alam, M. A., Ashafaq, M., Samim, M., … Ahmad, F. J. (2016). Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia. International Journal of Biological Macromolecules, 91, 640-655.
    1. Ahmad, N., Al-Subaiec, A. M., Ahmad, R., Sharma, S., Alam, M. A., Ashafaq, M., … Ahmad, F. J. (2019). Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment. Artificial Cells, Nanomedicine and Biotechnology, 47(1), 475-490.
    1. Alici, H. A., Ekinci, D., & Beydemir, S. (2008). Intravenous anesthetics inhibit human paraoxonase- 1 (PON1) activity in vitro and in vivo. Clinical Biochemistry, 41, 1384-1390.

MeSH terms

LinkOut - more resources